..............page:843-852
Research progress of Rho/ROCK signal pathway
HAN Jia-yin;YI Yan;LIANG Ai-hua;ZHANG Yu-shi;LI Chun-ying;WANG Lian-mei;PAN Chen;ZHAO Yong;Key Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine;Institute of Chinese Materia Medica;China Academy of Chinese Medical Sciences;
..............page:853-859
..............page:860-865
..............page:866-872
..............page:873-878
..............page:879-885
..............page:886-891
..............page:892-897
..............page:898-906
Olaparib potentiates the antitumor effect of Taxol on 4T1 breast cancer
LAI Fang-fang;LI Jie;JI Ming;ZHOU Qin;WANG Li-yuan;WANG Chun-yang;CHEN Xiao-guang;State Key Laboratory of Bioactive Substances and Functions of Natural Medicines;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Department of Breast Surgery;Beijing Chao-Yang Hospital;
..............page:907-912
..............page:913-918
Investigating the effects of compound WS090152 on non-alcoholic fatty liver in mice
ZHOU Ying;LI Xiu-li;YI Qin;ZHANG Xiao-lin;TIAN Jin-ying;WANG Dong-mei;WU Song;YE Fei;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study;State Key Laboratory of Bioactive Substances and Functions of Natural Medicines;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Medical College of Chifeng University;
..............page:919-925
..............page:926-930
Establishment and application of cell models with stable expression of hOCTN1/2
WENG Ya-yun;JIN Li-sha;WANG Yu-qing;SONG Fei-feng;LI Li-ping;ZHOU Hui;ZENG Su;JIANG Hui-di;Laboratory of Pharmaceutical Analysis and Drug Metabolism;Zhejiang Province Key Laboratory of Anti-Cancer Drug Research;College of Pharmaceutical Sciences;Zhejiang University;Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals;Zhejiang University of Technology;
..............page:931-937
..............page:938-946
..............page:947-953
Design, synthesis and biological evaluation of oxadiazole derivatives as xanthine oxidase inhibitors
YAN Ding-an;ZHANG Lei;TIAN Jin-ying;YE Fei;XIAO Zhi-yan;Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;
..............page:954-960
..............page:961-964
..............page:965-971
Sulfur-containing derivatives as characteristic chemical markers in control of sulfur-fumigated Moutan Cortex
LI Xiu-yang;DUAN Su-min;LIU Huan-huan;XU Jin-di;KONG Ming;LIU Hong-quan;LI Song-lin;Department of Pharmaceutical Analysis;Affiliated Hospital of Integrated Traditional Chinese and Western Medicine;Nanjing University of Chinese Medicine;Department of Metabolomics;Jiangsu Province Academy of Traditional Chinese Medicine;Department of Neurology;Affiliated Hospital of Integrated Traditional Chinese and Western Medicine;Nanjing University of Chinese Medicine;
..............page:972-978
..............page:979-984
..............page:985-990
..............page:991-997
..............page:998-1003
..............page:1004-1009
..............page:1010-1016